|Date||Event Title||Place||Title of Lecture||Web Link|
|May-June 2015||ASCO Annual Meeting 2015||Chicago, USA||The ASCO Post
|25 May 2015||ASCO Post||ASCO ASCO Journal - Prof. Nicholas James|
25-29 September 2015
|ECCO 18 EuropeanCancer Congress||Vienna, Austria||
Dr. Nicholas James, professor of Clinical Oncology in the Cancer Centre Queen Elizabeth Hospital, Birmingham in the UK discusses at the ECC 2015 conference in Vienna results from STAMPEDE, a randomized clinical trial for men with locally advanced metastatic prostate cancer. This trial investigated the overall survival benefit with the use of adding docetaxel and/or zoledronic acid to the standard of care.
|Video Prof. Nicholas James|
|15-16 October 2015||SFUHO Hostmote||Arlanda, Sweden||Multimodal organ-sparing treatment with MIBC|
|12-15 November 2015||EMUC, New Paradigm in the Management of Prostate Cancer||Barcelona, Spain|
|19-21 November 2015||SAKK meeting||Zurich, Switzerland||Chemotherapy in Former High Risk Hormone Naive Prostate Cancer|
|4 December 2015||BAU Annual Congress Meeting||Antwerpen, Belgium||Quality or Controversy|
|4 December 2015||Annual mtg Dutch UroOncology Study Group||Utrecht, Netherlands|
This page has no content yet.